Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Ann Rheum Dis

Retrieve available abstracts of 166 articles:
HTML format
Text format



Single Articles


    October 2018
  1. SINGH JA
    Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?
    Ann Rheum Dis. 2018 Oct 9. pii: annrheumdis-2018-213694.
    PubMed     Text format    


  2. ZHU H, Wu LF, Mo XB, Lu X, et al
    Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213970.
    PubMed     Text format     Abstract available


  3. PARK JK, Lee YJ, Bitoun S, Winthrop KL, et al
    Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-214025.
    PubMed     Text format    


  4. MARTINEZ-PRAT L, Lucia D, Ibarra C, Mahler M, et al
    Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213818.
    PubMed     Text format    


    September 2018
  5. DIEKHOFF T, Ulas ST, Poddubnyy D, Schneider U, et al
    Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 29. pii: annrheumdis-2018-213904.
    PubMed     Text format     Abstract available


  6. TSUJI H, Ikari K, Ohmura K, Yano K, et al
    Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 19. pii: annrheumdis-2018-214022.
    PubMed     Text format    


  7. TAKEUCHI T, Genovese MC, Haraoui B, Li Z, et al
    Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213271.
    PubMed     Text format     Abstract available


  8. ROODENRIJS NMT, de Hair MJH, van der Goes MC, Jacobs JWG, et al
    Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213687.
    PubMed     Text format     Abstract available


    August 2018
  9. TEITSMA XM, Jacobs JWG, de Jong PHP, Hazes JMW, et al
    Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 29. pii: annrheumdis-2018-213767.
    PubMed     Text format    


  10. RIVELLESE F, Mauro D, Nerviani A, Pagani S, et al
    Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-213418.
    PubMed     Text format     Abstract available


  11. FERREIRA RJO, Ndosi M, de Wit M, Santos EJF, et al
    Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-214199.
    PubMed     Text format    


  12. VAN DELFT MAM, van der Woude D, Toes REM, Trouw LA, et al
    Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces.
    Ann Rheum Dis. 2018 Aug 14. pii: annrheumdis-2018-213724.
    PubMed     Text format    


  13. LANDEWE RBM
    Response to: 'Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewe.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214172.
    PubMed     Text format    


  14. VAN DER HELM-VAN MIL A
    Early identification of rheumatoid arthritis: the risk of overtreatment in perspective.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214156.
    PubMed     Text format    


  15. SMOLEN JS, van Vollenhoven RF, Florentinus S, Chen S, et al
    Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Ann Rheum Dis. 2018 Aug 3. pii: annrheumdis-2018-213502.
    PubMed     Text format     Abstract available


    July 2018
  16. BUSTAMANTE MF, Oliveira PG, Garcia-Carbonell R, Croft AP, et al
    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 30. pii: annrheumdis-2018-213103.
    PubMed     Text format     Abstract available


  17. JIN S, Chen H, Li Y, Zhong H, et al
    Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
    Ann Rheum Dis. 2018 Jul 25. pii: annrheumdis-2018-213511.
    PubMed     Text format     Abstract available


  18. BITOUN S, Miceli-Richard C, Verstuyft C, Juge PA, et al
    Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
    Ann Rheum Dis. 2018 Jul 20. pii: annrheumdis-2018-213183.
    PubMed     Text format    


  19. JANS L, De Kock I, Herregods N, Verstraete KL, et al
    Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213960.
    PubMed     Text format    


  20. WU H, Zhang G, Huang X, Liang C, et al
    Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213892.
    PubMed     Text format    


  21. LEE JY, Kang MJ, Choi JY, Park JS, et al
    Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 11. pii: annrheumdis-2018-213444.
    PubMed     Text format     Abstract available


  22. NEUMANN E, Schwarz MC, Hasseli R, Hulser ML, et al
    Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-212954.
    PubMed     Text format     Abstract available


  23. KEARSLEY-FLEET L, Davies R, De Cock D, Watson KD, et al
    Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-213378.
    PubMed     Text format     Abstract available


  24. DIAZ-GALLO LM, Ramskold D, Shchetynsky K, Folkersen L, et al
    Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 2. pii: annrheumdis-2018-213412.
    PubMed     Text format     Abstract available


    June 2018
  25. PAULSHUS SUNDLISAETER N, Aga AB, Olsen IC, Hammer HB, et al
    Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Ann Rheum Dis. 2018 Jun 22. pii: annrheumdis-2017-212830.
    PubMed     Text format     Abstract available


  26. SOHRABIAN A, Mathsson-Alm L, Hansson M, Knight A, et al
    Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jun 12. pii: annrheumdis-2017-212627.
    PubMed     Text format     Abstract available


  27. FILIPPOU G, Sakellariou G, Scire CA, Carrara G, et al
    The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the
    Ann Rheum Dis. 2018 Jun 9. pii: annrheumdis-2018-213217.
    PubMed     Text format     Abstract available


  28. HILLIQUIN S, Hugues B, Mitrovic S, Gossec L, et al
    Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.
    Ann Rheum Dis. 2018 Jun 8. pii: annrheumdis-2017-212612.
    PubMed     Text format     Abstract available


  29. MICHELSEN B, Uhlig T, Sexton J, van der Heijde D, et al
    Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
    Ann Rheum Dis. 2018 Jun 6. pii: annrheumdis-2018-213286.
    PubMed     Text format     Abstract available


    May 2018
  30. KANEKO Y, Kato M, Tanaka Y, Inoo M, et al
    Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SUR
    Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213416.
    PubMed     Text format     Abstract available


  31. TEITSMA XM, Jacobs JWG, Welsing PMJ, de Jong PHP, et al
    Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
    Ann Rheum Dis. 2018 May 14. pii: annrheumdis-2018-213035.
    PubMed     Text format     Abstract available


  32. LAUPER K, Nordstrom DC, Pavelka K, Hernandez MV, et al
    Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modi
    Ann Rheum Dis. 2018 May 5. pii: annrheumdis-2017-212845.
    PubMed     Text format     Abstract available


  33. HEDSTROM AK, Klareskog L, Alfredsson L
    Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.
    Ann Rheum Dis. 2018 May 3. pii: annrheumdis-2018-212973.
    PubMed     Text format     Abstract available


    April 2018
  34. BOER AC, Boeters DM, van der Helm-van Mil AHM
    The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?
    Ann Rheum Dis. 2018 Apr 20. pii: annrheumdis-2018-213143.
    PubMed     Text format     Abstract available


  35. CHEN YM, Liao TL, Chen HH, Chen DY, et al
    Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 19. pii: annrheumdis-2018-213097.
    PubMed     Text format    


  36. SANTOS EJF, Duarte C, Ferreira RJO, Pinto AM, et al
    Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach.
    Ann Rheum Dis. 2018 Apr 6. pii: annrheumdis-2017-212934.
    PubMed     Text format     Abstract available


  37. BONDT A, Hafkenscheid L, Falck D, Kuijper TM, et al
    ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 3. pii: annrheumdis-2018-212946.
    PubMed     Text format     Abstract available


    March 2018
  38. RUTHERFORD AI, Subesinghe S, Hyrich KL, Galloway JB, et al
    Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatolgy Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2017-212825.
    PubMed     Text format     Abstract available


  39. BUCH MH
    Defining refractory rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 27. pii: annrheumdis-2017-212862.
    PubMed     Text format     Abstract available


  40. PARK JK, Lee YJ, Shin K, Ha YJ, et al
    Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2018 Mar 23. pii: annrheumdis-2018-213222.
    PubMed     Text format     Abstract available


  41. COHEN SB, Alonso-Ruiz A, Klimiuk PA, Lee EC, et al
    Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212245.
    PubMed     Text format     Abstract available


  42. LEONARD D, Svenungsson E, Dahlqvist J, Alexsson A, et al
    Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212614.
    PubMed     Text format     Abstract available


  43. GADEHOLT O
    Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 6. pii: annrheumdis-2018-213278.
    PubMed     Text format    


  44. JANS L, De Kock I, Herregods N, Verstraete K, et al
    Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2018-213152.
    PubMed     Text format    


  45. JUST SA, Rostgaard K, Titlestad K, Edgren G, et al
    Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2017-212844.
    PubMed     Text format    


    February 2018
  46. TAYLOR PC, Schiff MH, Wang Q, Jiang Y, et al
    Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
    Ann Rheum Dis. 2018 Feb 26. pii: annrheumdis-2017-212496.
    PubMed     Text format     Abstract available


  47. STEMMLER F, Simon D, Liphardt AM, Englbrecht M, et al
    Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures.
    Ann Rheum Dis. 2018 Feb 23. pii: annrheumdis-2017-212404.
    PubMed     Text format     Abstract available


  48. LI HZ, Xu XH, Lin N, Lu HD, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2018-213157.
    PubMed     Text format    


  49. DE PABLO P, Romaguera D, Fisk HL, Calder PC, et al
    High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case-control study.
    Ann Rheum Dis. 2018 Feb 7. pii: annrheumdis-2017-212274.
    PubMed     Text format     Abstract available


  50. ZEISBRICH M, Yanes RE, Zhang H, Watanabe R, et al
    Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation.
    Ann Rheum Dis. 2018 Feb 3. pii: annrheumdis-2017-212647.
    PubMed     Text format     Abstract available


    January 2018
  51. VAN HOOVELS L, Jacobs J, Vander Cruyssen B, Van den Bremt S, et al
    Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 23. pii: annrheumdis-2017-212365.
    PubMed     Text format     Abstract available


  52. VAN VOLLENHOVEN RF, Keystone EC, Strand V, Pacheco-Tena C, et al
    Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
    Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478.
    PubMed     Text format     Abstract available


  53. CHEVREAU M, Paclet MH, Romand X, Quesada JL, et al
    Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al.
    Ann Rheum Dis. 2018 Jan 10. pii: annrheumdis-2017-212816.
    PubMed     Text format    


  54. BOER AC, Huizinga TWJ, van der Helm-van Mil AHM
    Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 8. pii: annrheumdis-2017-212867.
    PubMed     Text format    


  55. RADNER H, Chatzidionysiou K, Nikiphorou E, Gossec L, et al
    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 4. pii: annrheumdis-2017-212256.
    PubMed     Text format     Abstract available


  56. AKDEMIR G, Heimans L, Bergstra SA, Goekoop RJ, et al
    Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
    Ann Rheum Dis. 2018;77:111-118.
    PubMed     Text format     Abstract available


  57. SCHONAU V, Vogel K, Englbrecht M, Wacker J, et al
    The value of (18)F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
    Ann Rheum Dis. 2018;77:70-77.
    PubMed     Text format     Abstract available


  58. WANG-RENAULT SF, Boudaoud S, Nocturne G, Roche E, et al
    Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:133-140.
    PubMed     Text format     Abstract available


    December 2017
  59. CURTIS JR, Xie F, Chen L, Saag KG, et al
    Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Ann Rheum Dis. 2017 Dec 21. pii: annrheumdis-2017-211727.
    PubMed     Text format     Abstract available


  60. MATSUNO H, Tomomitsu M, Hagino A, Shin S, et al
    Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding
    Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172.
    PubMed     Text format     Abstract available


  61. FRAENKEL L, Nowell WB, Michel G, Wiedmeyer C, et al
    Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212407.
    PubMed     Text format     Abstract available


  62. CORDTZ RL, Hawley S, Prieto-Alhambra D, Hojgaard P, et al
    Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212424.
    PubMed     Text format     Abstract available


  63. DREYER L, Cordtz RL, Hansen IMJ, Kristensen LE, et al
    Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
    Ann Rheum Dis. 2017 Dec 7. pii: annrheumdis-2017-212086.
    PubMed     Text format     Abstract available


  64. GAUJOUX-VIALA C, Rincheval N, Dougados M, Combe B, et al
    Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Ann Rheum Dis. 2017;76:2054-2060.
    PubMed     Text format     Abstract available


  65. TSUBOI H, Hagiwara S, Asashima H, Takahashi H, et al
    Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome with other sets of criteria in Japanese patients.
    Ann Rheum Dis. 2017;76:1980-1985.
    PubMed     Text format     Abstract available


    November 2017
  66. SMILJANOVIC B, Radzikowska A, Kuca-Warnawin E, Kurowska W, et al
    Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.
    Ann Rheum Dis. 2017 Nov 30. pii: annrheumdis-2017-211649.
    PubMed     Text format     Abstract available


  67. HENAUX S, Ruyssen-Witrand A, Cantagrel A, Barnetche T, et al
    Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
    Ann Rheum Dis. 2017 Nov 29. pii: annrheumdis-2017-212423.
    PubMed     Text format     Abstract available


  68. WEIJERS JM, Rongen-van Dartel SAA, Hoevenaars DMGMF, Rubens M, et al
    Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Ann Rheum Dis. 2017 Nov 22. pii: annrheumdis-2017-212392.
    PubMed     Text format     Abstract available


  69. MO WX, Yin SS, Chen H, Zhang X, et al
    Amino-bisphosphonates, gammadeltaT cells, and their roles in Rheumatoid Arthritis.
    Ann Rheum Dis. 2017 Nov 17. pii: annrheumdis-2017-212569.
    PubMed     Text format    


  70. KAVANAUGH A, van Vollenhoven R, Fleischmann RM, Emery P, et al
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871.
    PubMed     Text format     Abstract available


  71. L'AMI MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
    Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602.
    PubMed     Text format    


  72. GOSSEC L, Chauvin P, Saraux A, Hudry C, et al
    Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.
    Ann Rheum Dis. 2017 Nov 4. pii: annrheumdis-2017-212000.
    PubMed     Text format     Abstract available


  73. CORDTZ RL, Zobbe K, Hojgaard P, Kristensen LE, et al
    Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
    Ann Rheum Dis. 2017 Nov 2. pii: annrheumdis-2017-212339.
    PubMed     Text format     Abstract available


  74. MOSSEL E, Delli K, van Nimwegen JF, Stel AJ, et al
    Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1883-1889.
    PubMed     Text format     Abstract available


  75. DEN BROEDER AA, van den Bemt BJF
    Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'.
    Ann Rheum Dis. 2017 Nov 1. pii: annrheumdis-2017-212579.
    PubMed     Text format    


    October 2017
  76. ROSSINI M, Adami G, Viapiana O, Idolazzi L, et al
    Rheumatoid arthritis, gammadelta T cells and bisphosphonates.
    Ann Rheum Dis. 2017 Oct 26. pii: annrheumdis-2017-212510.
    PubMed     Text format    


  77. SHI J, Darrah E, Sims GP, Mustelin T, et al
    Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211489.
    PubMed     Text format     Abstract available


  78. RONNELID J, Hansson M, Mathsson-Alm L, Cornillet M, et al
    Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211782.
    PubMed     Text format     Abstract available


  79. SMOLEN JS, Choe JY, Prodanovic N, Niebrzydowski J, et al
    Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition st
    Ann Rheum Dis. 2017 Oct 17. pii: annrheumdis-2017-211741.
    PubMed     Text format     Abstract available


  80. ERIKSSON K, Nise L, Alfredsson L, Catrina AI, et al
    Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 6. pii: annrheumdis-2017-212091.
    PubMed     Text format    


  81. BRAUNER S, Folkersen L, Kvarnstrom M, Meisgen S, et al
    H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Ann Rheum Dis. 2017;76:1755-1763.
    PubMed     Text format     Abstract available


  82. HAACKE EA, van der Vegt B, Vissink A, Spijkervet FKL, et al
    Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren's syndrome are not predictive for parotid MALT lymphoma development.
    Ann Rheum Dis. 2017;76:1781-1784.
    PubMed     Text format     Abstract available


  83. BURGERS LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, et al
    Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Ann Rheum Dis. 2017;76:1751-1754.
    PubMed     Text format     Abstract available


    September 2017
  84. HOLMQVIST M, Ljung L, Askling J
    Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
    Ann Rheum Dis. 2017 Sep 26. pii: annrheumdis-2017-212131.
    PubMed     Text format     Abstract available


  85. REMPENAULT C, Combe B, Barnetche T, Gaujoux-Viala C, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017 Sep 25. pii: annrheumdis-2017-211836.
    PubMed     Text format     Abstract available


  86. MORITA T, Fujimoto K, Shima Y, Ogata A, et al
    Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-212366.
    PubMed     Text format    


  87. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211781.
    PubMed     Text format     Abstract available


  88. ROBERTSON J, Porter D, Sattar N, Packard CJ, et al
    Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-211708.
    PubMed     Text format     Abstract available


  89. ZENG P, Chen Z, Klareskog L, Alfredsson L, et al
    Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-212145.
    PubMed     Text format    


  90. CROWSON CS, Rollefstad S, Ikdahl E, Kitas GD, et al
    Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 6. pii: annrheumdis-2017-211735.
    PubMed     Text format     Abstract available


  91. MO WX, Yin SS, Chen H, Zhou C, et al
    Chemotaxis of Vdelta2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2016-211069.
    PubMed     Text format     Abstract available


  92. BREBAN M, Tap J, Leboime A, Said-Nahal R, et al
    Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Ann Rheum Dis. 2017;76:1614-1622.
    PubMed     Text format     Abstract available


    August 2017
  93. TAKEUCHI T, Thorne C, Karpouzas G, Sheng S, et al
    Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
    Ann Rheum Dis. 2017 Aug 30. pii: annrheumdis-2017-211328.
    PubMed     Text format     Abstract available


  94. FILER A, Ward LSC, Kemble S, Davies CS, et al
    Identification of a transitional fibroblast function in very early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 28. pii: annrheumdis-2017-211286.
    PubMed     Text format     Abstract available


  95. OIWA H
    Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212206.
    PubMed     Text format    


  96. ORYOJI K, Yoshida K, Kashiwado Y, Tanaka K, et al
    Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-211430.
    PubMed     Text format    


  97. OLSEN CM, Green AC
    Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212205.
    PubMed     Text format    


  98. MANTEL A, Holmqvist M, Jernberg T, Wallberg-Jonsson S, et al
    Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 20. pii: annrheumdis-2017-211608.
    PubMed     Text format     Abstract available


  99. MERCER LK, Regierer AC, Mariette X, Dixon WG, et al
    Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
    Ann Rheum Dis. 2017 Aug 19. pii: annrheumdis-2017-211623.
    PubMed     Text format     Abstract available


  100. ORELLANA C, Saevarsdottir S, Klareskog L, Karlson EW, et al
    Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Ann Rheum Dis. 2017 Aug 17. pii: annrheumdis-2017-211620.
    PubMed     Text format     Abstract available


  101. JONSSON MK, Sundlisaeter NP, Nordal HH, Hammer HB, et al
    Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 16. pii: annrheumdis-2017-211695.
    PubMed     Text format     Abstract available


  102. SCALLY SW, Law SC, Ting YT, Heemst JV, et al
    Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2017-211300.
    PubMed     Text format     Abstract available


  103. BRINKMANN GH, Norli ES, Boyesen P, Heijde DVH, et al
    Role of erosions typical of rheumatoid arthritis in the 2010 ACR/EULAR rheumatoid arthritis classification criteria: results from a very early arthritis cohort.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211350.
    PubMed     Text format     Abstract available


  104. KEYSTONE EC, Taylor PC, Tanaka Y, Gaich C, et al
    Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211259.
    PubMed     Text format     Abstract available


  105. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
    Ann Rheum Dis. 2017 Aug 9. pii: annrheumdis-2017-211591.
    PubMed     Text format     Abstract available


  106. TAK PP, Doorenspleet ME, de Hair MJH, Klarenbeek PL, et al
    Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 8. pii: annrheumdis-2017-211351.
    PubMed     Text format     Abstract available


  107. DE JONG AJ, Klein-Wieringa IR, Kwekkeboom JC, Toes REM, et al
    Inflammatory features of infrapatellar fat pad in rheumatoid arthritis versus osteoarthritis reveal mostly qualitative differences.
    Ann Rheum Dis. 2017 Aug 5. pii: annrheumdis-2017-211673.
    PubMed     Text format    


  108. CAPORALI R, Smolen JS
    Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management.
    Ann Rheum Dis. 2017 Aug 2. pii: annrheumdis-2017-211458.
    PubMed     Text format     Abstract available


  109. BAKER KF, Isaacs JD
    Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
    Ann Rheum Dis. 2017 Aug 1. pii: annrheumdis-2017-211555.
    PubMed     Text format     Abstract available


  110. TASAKI S, Suzuki K, Nishikawa A, Kassai Y, et al
    Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1458-1466.
    PubMed     Text format     Abstract available


  111. LISNEY AR, Szelinski F, Reiter K, Burmester GR, et al
    High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Ann Rheum Dis. 2017;76:1476-1480.
    PubMed     Text format     Abstract available


  112. GLINTBORG B, Sorensen IJ, Loft AG, Lindegaard H, et al
    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
    Ann Rheum Dis. 2017;76:1426-1431.
    PubMed     Text format     Abstract available


  113. DEKKERS JS, Verheul MK, Stoop JN, Liu B, et al
    Breach of autoreactive B cell tolerance by post-translationally modified proteins.
    Ann Rheum Dis. 2017;76:1449-1457.
    PubMed     Text format     Abstract available


  114. SCHIEIR O, Tosevski C, Glazier RH, Hogg-Johnson S, et al
    Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017;76:1396-1404.
    PubMed     Text format     Abstract available


  115. MORADI-LAKEH M, Forouzanfar MH, Vollset SE, El Bcheraoui C, et al
    Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.
    Ann Rheum Dis. 2017;76:1365-1373.
    PubMed     Text format     Abstract available


    July 2017
  116. MICHELSEN B, Kristianslund EK, Sexton J, Hammer HB, et al
    Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
    Ann Rheum Dis. 2017 Jul 21. pii: annrheumdis-2017-211284.
    PubMed     Text format     Abstract available


  117. HOLMQVIST M, Ljung L, Askling J
    Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Ann Rheum Dis. 2017 Jul 14. pii: annrheumdis-2016-211066.
    PubMed     Text format     Abstract available


  118. VAN SCHIE KA, Ooijevaar-De Heer P, Kruithof S, Plasencia C, et al
    Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.
    Ann Rheum Dis. 2017;76:1285-1288.
    PubMed     Text format     Abstract available


  119. BOUTET MA, Najm A, Bart G, Brion R, et al
    IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
    Ann Rheum Dis. 2017;76:1304-1312.
    PubMed     Text format     Abstract available


  120. VAN ZANTEN A, Arends S, Roozendaal C, Limburg PC, et al
    Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.
    Ann Rheum Dis. 2017;76:1184-1190.
    PubMed     Text format     Abstract available


  121. FISHER BA, Jonsson R, Daniels T, Bombardieri M, et al
    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1161-1168.
    PubMed     Text format     Abstract available


    June 2017
  122. CHEN YM, Huang WN, Wu YD, Lin CT, et al
    Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study.
    Ann Rheum Dis. 2017 Jun 29. pii: annrheumdis-2017-211322.
    PubMed     Text format    


  123. RUBBERT-ROTH A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ, et al
    A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.
    Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485.
    PubMed     Text format    


  124. SMOLEN JS, Cohen SB, Tony HP, Scheinberg M, et al
    A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 21. pii: annrheumdis-2017-211281.
    PubMed     Text format     Abstract available


  125. HYLDGAARD C, Hilberg O, Pedersen AB, Ulrichsen SP, et al
    A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211138.
    PubMed     Text format     Abstract available


  126. GLINATSI D, Baker JF, Hetland ML, Horslev-Petersen K, et al
    Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled tr
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211315.
    PubMed     Text format     Abstract available


  127. GEORGE MD, Ostergaard M, Conaghan PG, Emery P, et al
    Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211569.
    PubMed     Text format     Abstract available


  128. ARTS EE, Fransen J, Den Broeder AA, van Riel PLCM, et al
    Low disease activity (DAS28</=3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2016-210997.
    PubMed     Text format     Abstract available


  129. BOUMAN CA, Herwaarden NV, van den Hoogen FH, Fransen J, et al
    Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211169.
    PubMed     Text format     Abstract available


  130. BELKHIR R, Burel SL, Dunogeant L, Marabelle A, et al
    Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Ann Rheum Dis. 2017 Jun 9. pii: annrheumdis-2017-211216.
    PubMed     Text format     Abstract available


  131. HUMPHREYS JH, Costello R, Verstappen SM, Dixon WG, et al
    Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211670.
    PubMed     Text format    


  132. KREMER JM, Weinblatt ME
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211632.
    PubMed     Text format    


  133. THOMSEN T, Aadahl M, Beyer N, Hetland ML, et al
    The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210953.
    PubMed     Text format     Abstract available


  134. COHEN S, Genovese MC, Choy E, Perez-Ruiz F, et al
    Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210459.
    PubMed     Text format     Abstract available


  135. BRITO-ZERON P, Acar-Denizli N, Zeher M, Rasmussen A, et al
    Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium.
    Ann Rheum Dis. 2017;76:1042-1050.
    PubMed     Text format     Abstract available


    May 2017
  136. MEISSNER Y, Richter A, Manger B, Tony HP, et al
    Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
    Ann Rheum Dis. 2017 May 8. pii: annrheumdis-2017-211209.
    PubMed     Text format     Abstract available


  137. SMOLEN JS, Landewe RBM, van der Heijde D
    Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra et al.
    Ann Rheum Dis. 2017 May 6. pii: annrheumdis-2017-211455.
    PubMed     Text format    


  138. BUTTGEREIT F, Bijlsma JW
    Glucocorticoids in rheumatoid arthritis: the picture is shaping up.
    Ann Rheum Dis. 2017 May 4. pii: annrheumdis-2017-211187.
    PubMed     Text format    


  139. PARK JK, Lee MA, Lee EY, Song YW, et al
    Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2017 May 3. pii: annrheumdis-2017-211128.
    PubMed     Text format     Abstract available


  140. OGDIE A, Harter L, Shin D, Baker J, et al
    The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
    Ann Rheum Dis. 2017;76:882-885.
    PubMed     Text format     Abstract available


    April 2017
  141. SAFY M, Jacobs J, IJff ND, Bijlsma J, et al
    Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2016-210647.
    PubMed     Text format     Abstract available


  142. PIRILA L, Sokka T, Kauppi MJ, Rantalaiho VM, et al
    Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2017-211505.
    PubMed     Text format    


  143. CRUZ GI, Shao X, Quach H, Ho KA, et al
    Increased risk of rheumatoid arthritis among mothers with children who carry DRB1 risk-associated alleles.
    Ann Rheum Dis. 2017 Apr 8. doi: 10.1136/annrheumdis-2016-210662.
    PubMed     Text format     Abstract available


  144. BURMESTER GR, Rigby WF, van Vollenhoven RF, Kay J, et al
    Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210561.
    PubMed     Text format     Abstract available


    March 2017
  145. CHATZIDIONYSIOU K, Emamikia S, Nam J, Ramiro S, et al
    Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711.
    PubMed     Text format     Abstract available


  146. MISRA DP, Agarwal V, Sharma A, Wakhlu A, et al
    2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
    Ann Rheum Dis. 2017 Mar 27. pii: annrheumdis-2017-211446.
    PubMed     Text format    


  147. HUMPHREYS JH, Warner A, Costello R, Lunt M, et al
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210629.
    PubMed     Text format     Abstract available


  148. MANIVEL VA, Mullazehi M, Padyukov L, Westerlind H, et al
    Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210873.
    PubMed     Text format     Abstract available


  149. CHARRAS A, Konsta OD, Le Dantec C, Bagacean C, et al
    Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:625-628.
    PubMed     Text format     Abstract available


  150. ROSS EA, Naylor AJ, O'Neil JD, Crowley T, et al
    Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
    Ann Rheum Dis. 2017;76:612-619.
    PubMed     Text format     Abstract available


  151. THORARENSEN SM, Lu N, Ogdie A, Gelfand JM, et al
    Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
    Ann Rheum Dis. 2017;76:521-525.
    PubMed     Text format     Abstract available


    February 2017
  152. MAEHARA T, Mattoo H, Ohta M, Mahajan VS, et al
    Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Ann Rheum Dis. 2017;76:377-385.
    PubMed     Text format     Abstract available


  153. ROSSETTI M, Spreafico R, Consolaro A, Leong JY, et al
    TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.
    Ann Rheum Dis. 2017;76:435-441.
    PubMed     Text format     Abstract available


  154. NORDBERG LB, Lillegraven S, Lie E, Aga AB, et al
    Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR/EULAR criteria.
    Ann Rheum Dis. 2017;76:341-345.
    PubMed     Text format     Abstract available


    January 2017
  155. ALAWI KM, Russell FA, Aubdool AA, Srivastava S, et al
    Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
    Ann Rheum Dis. 2017;76:252-260.
    PubMed     Text format     Abstract available


  156. BELL GM, Anderson AE, Diboll J, Reece R, et al
    Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
    Ann Rheum Dis. 2017;76:227-234.
    PubMed     Text format     Abstract available


  157. DOUGADOS M, van der Heijde D, Chen YC, Greenwald M, et al
    Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
    Ann Rheum Dis. 2017;76:88-95.
    PubMed     Text format     Abstract available


  158. SHIBOSKI CH, Shiboski SC, Seror R, Criswell LA, et al
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Ann Rheum Dis. 2017;76:9-16.
    PubMed     Text format     Abstract available


  159. CAPPELLI LC, Gutierrez AK, Baer AN, Albayda J, et al
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Ann Rheum Dis. 2017;76:43-50.
    PubMed     Text format     Abstract available


  160. HENSVOLD AH, Frisell T, Magnusson PK, Holmdahl R, et al
    How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Ann Rheum Dis. 2017;76:119-125.
    PubMed     Text format     Abstract available


  161. CHOE JY, Prodanovic N, Niebrzydowski J, Staykov I, et al
    A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:58-64.
    PubMed     Text format     Abstract available


  162. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:51-57.
    PubMed     Text format     Abstract available


    October 2016
  163. HUNT L, Hensor EM, Nam J, Burska AN, et al
    T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.
    Ann Rheum Dis. 2016;75:1884-9.
    PubMed     Text format     Abstract available


  164. VAN HEEMST J, Hensvold AH, Jiang X, van Steenbergen H, et al
    Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    Ann Rheum Dis. 2016;75:1891-8.
    PubMed     Text format     Abstract available


  165. CORSIERO E, Bombardieri M, Carlotti E, Pratesi F, et al
    Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
    Ann Rheum Dis. 2016;75:1866-75.
    PubMed     Text format     Abstract available


  166. VAN STEENBERGEN HW, Mangnus L, Reijnierse M, Huizinga TW, et al
    Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    Ann Rheum Dis. 2016;75:1824-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: